4/24
07:57 am
nvs
Novartis Secures Positive EU Backing for SMA Gene Therapy Itvisma [Yahoo! Finance]
Low
Report
Novartis Secures Positive EU Backing for SMA Gene Therapy Itvisma [Yahoo! Finance]
4/24
06:46 am
nvs
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA) [Yahoo! Finance]
Low
Report
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA) [Yahoo! Finance]
4/24
01:25 am
nvs
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants [Yahoo! Finance]
Low
Report
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants [Yahoo! Finance]
4/24
01:15 am
nvs
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
Low
Report
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
4/21
12:26 pm
nvs
Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade) [Seeking Alpha]
Low
Report
Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade) [Seeking Alpha]
4/20
09:27 am
nvs
Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma [Yahoo! Finance]
Low
Report
Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma [Yahoo! Finance]
4/19
01:32 pm
nvs
Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns [Yahoo! Finance]
Low
Report
Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns [Yahoo! Finance]
4/19
08:14 am
nvs
String of scientist deaths, vanishings fuels expert talks of shadow ops and silenced secrets: 'Very serious' [FOX News]
Low
Report
String of scientist deaths, vanishings fuels expert talks of shadow ops and silenced secrets: 'Very serious' [FOX News]
4/19
04:03 am
nvs
Biotechnology Expands in Southern California [Los Angeles Times (CA)]
Low
Report
Biotechnology Expands in Southern California [Los Angeles Times (CA)]
4/17
08:02 pm
nvs
Nomination Committee's proposal to the Board of Directors for IRLAB Therapeutics' Annual General Meeting 2026 [Yahoo! Finance]
Low
Report
Nomination Committee's proposal to the Board of Directors for IRLAB Therapeutics' Annual General Meeting 2026 [Yahoo! Finance]
4/17
06:10 am
nvs
Missing general, scientist deaths tied to secret US work prompt White House probe [FOX News]
Low
Report
Missing general, scientist deaths tied to secret US work prompt White House probe [FOX News]
4/16
07:41 pm
nvs
Exclusive: Carrie Ann Inaba reveals in-flight emergency, gives update [USA TODAY]
Low
Report
Exclusive: Carrie Ann Inaba reveals in-flight emergency, gives update [USA TODAY]
4/15
10:28 am
nvs
Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs [Yahoo! Finance]
Low
Report
Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs [Yahoo! Finance]
4/14
12:17 pm
nvs
Middle East and North Africa (MENA) Medical Device Regulatory Requirements and Developments Course: Navigate Product Approvals and Capitalize on the Region's Growing Demand (May 18th - May 19th, 2026) [Yahoo! Finance]
Neutral
Report
Middle East and North Africa (MENA) Medical Device Regulatory Requirements and Developments Course: Navigate Product Approvals and Capitalize on the Region's Growing Demand (May 18th - May 19th, 2026) [Yahoo! Finance]
4/9
01:15 am
nvs
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
Low
Report
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
4/3
09:36 am
nvs
US tariffs raise fears for European pharmaceutical sites [Yahoo! Finance]
Low
Report
US tariffs raise fears for European pharmaceutical sites [Yahoo! Finance]
4/2
12:55 pm
nvs
Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR [Yahoo! Finance]
Low
Report
Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR [Yahoo! Finance]
4/2
11:08 am
nvs
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE-IgAN Study [Yahoo! Finance]
Low
Report
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE-IgAN Study [Yahoo! Finance]
4/1
08:04 pm
nvs
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development [Yahoo! Finance]
Low
Report
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development [Yahoo! Finance]
4/1
11:16 am
nvs
The Vanguard ETF Up About 28% in the Past Year That Almost Nobody Outside of Income Investors Knows [Yahoo! Finance]
Low
Report
The Vanguard ETF Up About 28% in the Past Year That Almost Nobody Outside of Income Investors Knows [Yahoo! Finance]
4/1
07:16 am
nvs
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development [TheStreet.com]
Low
Report
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development [TheStreet.com]
3/29
01:25 am
nvs
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% [Yahoo! Finance]
Low
Report
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% [Yahoo! Finance]
3/27
04:17 pm
nvs
Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance [Yahoo! Finance]
Low
Report
Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance [Yahoo! Finance]
3/27
12:22 pm
nvs
Novartis Agrees Up to $2B Excellergy Deal Amid Generic Pressure [Yahoo! Finance]
Low
Report
Novartis Agrees Up to $2B Excellergy Deal Amid Generic Pressure [Yahoo! Finance]
3/27
08:13 am
nvs
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week [MSNBC.com]
Low
Report
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week [MSNBC.com]